References
- Barry AL, Jones RN, Thornsberry C, Ayers LW, Gerlach EH, Sommer s HM. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin and nalidixic acid. Antimicrob Agents Chemother 1984; 25: 633–637.
- Chin NX, Neu HC. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother. 1984; 25: 319–326.
- Wolfson JA, Hooper DC. The fluoroquinolones: structures, mechanisms of action and resistance and spectra of activity in vitro. Antimicrob Agents Chemother 1985; 28: 716–721.
- Barry LB, Jones RN. In vitro activity of ciprofloxacin against gram-positive cocci. Am J Med 1987; 82 (S 4 A): 27–32.
- Crump B, Wise R, Dent J. The pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother 1983; 24: 784–786.
- Fass RJ. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections. Am J Med 1987; 82 (S 4A): 202–207.
- Gasser TC, Graversen PH, Madsen PO. Treatment of complicated urinary tract infections with ciprofloxacin. Am J Med 1987; 82 (S 4 A): 278–283.
- Bonadio M, Maccanti O, Cosci S, Benvenuti S, Giordani R. Comparative in vitro activity of imipenem and nine other antimicrobials against recently isolated pathogens. Proceedings, 6th Mediterranean Congress of Chemotherapy. J Chemother 1989; 1 (suppl. 4): 58–60.
- Cox C. Brief report: Ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas species and organisms resistant to trimethoprim/sulphamethoxazole. Am J Med 1987; 82 (S 4 A): 288–289.
- Giamarellou H, Galanakis N. Use of intravenous ciprofloxacin in difficult-to-treat infections. Am J Med 1987; 82 (S 4 A): 346–351.